Medivation
Sanofi starts proceedings to remove Medivation’s board of directors
Sanofi has filed documents seeking to remove the current Medivation board of directors and replace it with eight individuals that are willing to “fairly evaluate” Sanofi’s acquisition offer Read more
Medivation and Sanofi play cat and mouse
Sanofi has filed for a pre-merger notification regarding its intention to acquire Medivation, suggesting an acquisition could be back on the cards Read more
Sanofi makes power play for Medivation
Sanofi threatens to go direct to the shareholders if Medivation's board of directors continue to resist an acquisition by the big pharma player Read more
Sanofi offer rejected by Medivation
Medivation, today announced that its board of directors unanimously rejected the proposal from Sanofi to acquire Medivation for £36.09 ($52.50) per share in cash Read more
Sanofi offers to acquire Medivation for £6.4bn
Sanofi today announced that it has sent a letter to Medivation, in which it makes a proposal to acquire Medivation for £36.09 ($52.50) per share, which would represent an all-cash transaction valued at approximately £6.4bn ($9.3bn) Read more
